Board Meetings for ERIS

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
ERISEris Lifesciences Limited26 Jun 2020Financial ResultsTo consider and approve the financial results for the period ended March 31, 2020
ERISEris Lifesciences Limited02 Jun 2020Financial ResultsTo consider and approve the financial results for the period ended March 31, 2020
ERISEris Lifesciences Limited11 Mar 2020DividendTo consider�� interim dividend��
ERISEris Lifesciences Limited14 Feb 2020Financial ResultsTo consider and approve the financial results for the period ended December 31, 2019
ERISEris Lifesciences Limited07 Nov 2019Financial ResultsTo consider and approve the financial results for the period ended September 30, 2019
ERISEris Lifesciences Limited27 Jul 2019Financial ResultsTo consider and approve the financial results for the period ended June 30, 2019
ERISEris Lifesciences Limited03 Jul 2019BuybackTo consider buyback for equity shares
ERISEris Lifesciences Limited21 May 2019Financial ResultsTo consider and approve the financial results for the quarter and year March 31, 2019
ERISEris Lifesciences Limited29 Jan 2019Financial ResultsTo consider and approve the financial results for the period ended December 31, 2018
ERISEris Lifesciences Limited03 Nov 2018Financial ResultsTo consider and approve the financial results for the period ended September 30, 2018
ERISEris Lifesciences Limited09 Aug 2018Financial Results/Other business mattersTo consider and approve the financial results for the period ended Jun 30, 2018 and other business matters
ERISEris Lifesciences Limited25 May 2018Financial ResultsTo consider and approve the standalone and consolidated audited financial results of the Company for the quarter and year ended March 31, 2018
ERISEris Lifesciences Limited12 Feb 2018ResultsTo, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended December 31, 2017.��
ERISEris Lifesciences Limited18 Nov 2017ResultsTo, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter / Half year ended September 30, 2017.
ERISEris Lifesciences Limited17 Aug 2017ResultsTo, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter /Three months ended June 30, 2017.
Showing page 4 of 4 (60 total items)